Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer.
Guo Y, Jie X, Zhang A, Zhang W, Wang R, Zhang J, Mao S, Wu Y, Wang L, Zhang Z, Yan Y, Wang P, Yao X.
Guo Y, et al. Among authors: wang l, wang p, wang r.
Front Oncol. 2019 Dec 6;9:1315. doi: 10.3389/fonc.2019.01315. eCollection 2019.
Front Oncol. 2019.
PMID: 31867271
Free PMC article.